Visual manifestations in giant cell arteritis: Trend over 5 decades in a population-based cohort

Abha G. Singh, Tanaz A. Kermani, Cynthia Crowson, Cornelia M. Weyand, Eric Lawrence Matteson, Kenneth J Warrington

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Objective. To evaluate clinical characteristics, treatment, and outcomes of patients with visual changes from giant cell arteritis (GCA) and to examine trends over the last 5 decades. Methods. We reviewed the medical records of a population-based cohort of patients with GCA diagnosed between 1950 and 2004. The clinical, ophthalmological, and laboratory features of patients with visual manifestations attributable to GCA were compared to patients without visual complications. Trends over time were examined using logistic regression modeling adjusted for age and sex. Results. In a cohort of 204 cases of GCA (mean age 76.0 ± 8.2 yrs, 80% female), visual changes from GCA were observed in 47 patients (23%), and 4.4% suffered complete vision loss. A higher proportion of patients with visual manifestations reported jaw claudication than did patients without visual changes (55% vs 38%, p = 0.04). Over a period of 55 years, we observed a significant decline in the incidence of visual symptoms due to GCA. There was a lower incidence of ischemic optic neuropathy in the 1980-2004 cohort vs 1950-1979 (6% vs 15%, p = 0.03). Patients diagnosed in later decades were more likely to recover from visual symptoms (HR 1.34, 95% CI 1.06-1.71). Chances of recovery were poor in patients with anterior ischemic optic neuropathy or complete vision loss. Conclusion. Incidence of visual symptoms has declined over the past 5 decades, and chances of recovery from visual symptoms have improved. However, complete loss of vision is essentially irreversible. Jaw claudication is associated with higher likelihood of development of visual symptoms.

Original languageEnglish (US)
Pages (from-to)309-315
Number of pages7
JournalJournal of Rheumatology
Volume42
Issue number2
StatePublished - Feb 1 2015

Fingerprint

Giant Cell Arteritis
Population
Ischemic Optic Neuropathy
Jaw
Incidence
Medical Records
Logistic Models

Keywords

  • Blindness
  • Giant cell arteritis
  • Steroids
  • Vasculitis
  • Vision loss
  • Visual manifestations

ASJC Scopus subject areas

  • Rheumatology
  • Immunology
  • Immunology and Allergy

Cite this

Visual manifestations in giant cell arteritis : Trend over 5 decades in a population-based cohort. / Singh, Abha G.; Kermani, Tanaz A.; Crowson, Cynthia; Weyand, Cornelia M.; Matteson, Eric Lawrence; Warrington, Kenneth J.

In: Journal of Rheumatology, Vol. 42, No. 2, 01.02.2015, p. 309-315.

Research output: Contribution to journalArticle

@article{7e2d0126ae2d46598fee633d9446e8b2,
title = "Visual manifestations in giant cell arteritis: Trend over 5 decades in a population-based cohort",
abstract = "Objective. To evaluate clinical characteristics, treatment, and outcomes of patients with visual changes from giant cell arteritis (GCA) and to examine trends over the last 5 decades. Methods. We reviewed the medical records of a population-based cohort of patients with GCA diagnosed between 1950 and 2004. The clinical, ophthalmological, and laboratory features of patients with visual manifestations attributable to GCA were compared to patients without visual complications. Trends over time were examined using logistic regression modeling adjusted for age and sex. Results. In a cohort of 204 cases of GCA (mean age 76.0 ± 8.2 yrs, 80{\%} female), visual changes from GCA were observed in 47 patients (23{\%}), and 4.4{\%} suffered complete vision loss. A higher proportion of patients with visual manifestations reported jaw claudication than did patients without visual changes (55{\%} vs 38{\%}, p = 0.04). Over a period of 55 years, we observed a significant decline in the incidence of visual symptoms due to GCA. There was a lower incidence of ischemic optic neuropathy in the 1980-2004 cohort vs 1950-1979 (6{\%} vs 15{\%}, p = 0.03). Patients diagnosed in later decades were more likely to recover from visual symptoms (HR 1.34, 95{\%} CI 1.06-1.71). Chances of recovery were poor in patients with anterior ischemic optic neuropathy or complete vision loss. Conclusion. Incidence of visual symptoms has declined over the past 5 decades, and chances of recovery from visual symptoms have improved. However, complete loss of vision is essentially irreversible. Jaw claudication is associated with higher likelihood of development of visual symptoms.",
keywords = "Blindness, Giant cell arteritis, Steroids, Vasculitis, Vision loss, Visual manifestations",
author = "Singh, {Abha G.} and Kermani, {Tanaz A.} and Cynthia Crowson and Weyand, {Cornelia M.} and Matteson, {Eric Lawrence} and Warrington, {Kenneth J}",
year = "2015",
month = "2",
day = "1",
language = "English (US)",
volume = "42",
pages = "309--315",
journal = "Journal of Rheumatology",
issn = "0315-162X",
publisher = "Journal of Rheumatology",
number = "2",

}

TY - JOUR

T1 - Visual manifestations in giant cell arteritis

T2 - Trend over 5 decades in a population-based cohort

AU - Singh, Abha G.

AU - Kermani, Tanaz A.

AU - Crowson, Cynthia

AU - Weyand, Cornelia M.

AU - Matteson, Eric Lawrence

AU - Warrington, Kenneth J

PY - 2015/2/1

Y1 - 2015/2/1

N2 - Objective. To evaluate clinical characteristics, treatment, and outcomes of patients with visual changes from giant cell arteritis (GCA) and to examine trends over the last 5 decades. Methods. We reviewed the medical records of a population-based cohort of patients with GCA diagnosed between 1950 and 2004. The clinical, ophthalmological, and laboratory features of patients with visual manifestations attributable to GCA were compared to patients without visual complications. Trends over time were examined using logistic regression modeling adjusted for age and sex. Results. In a cohort of 204 cases of GCA (mean age 76.0 ± 8.2 yrs, 80% female), visual changes from GCA were observed in 47 patients (23%), and 4.4% suffered complete vision loss. A higher proportion of patients with visual manifestations reported jaw claudication than did patients without visual changes (55% vs 38%, p = 0.04). Over a period of 55 years, we observed a significant decline in the incidence of visual symptoms due to GCA. There was a lower incidence of ischemic optic neuropathy in the 1980-2004 cohort vs 1950-1979 (6% vs 15%, p = 0.03). Patients diagnosed in later decades were more likely to recover from visual symptoms (HR 1.34, 95% CI 1.06-1.71). Chances of recovery were poor in patients with anterior ischemic optic neuropathy or complete vision loss. Conclusion. Incidence of visual symptoms has declined over the past 5 decades, and chances of recovery from visual symptoms have improved. However, complete loss of vision is essentially irreversible. Jaw claudication is associated with higher likelihood of development of visual symptoms.

AB - Objective. To evaluate clinical characteristics, treatment, and outcomes of patients with visual changes from giant cell arteritis (GCA) and to examine trends over the last 5 decades. Methods. We reviewed the medical records of a population-based cohort of patients with GCA diagnosed between 1950 and 2004. The clinical, ophthalmological, and laboratory features of patients with visual manifestations attributable to GCA were compared to patients without visual complications. Trends over time were examined using logistic regression modeling adjusted for age and sex. Results. In a cohort of 204 cases of GCA (mean age 76.0 ± 8.2 yrs, 80% female), visual changes from GCA were observed in 47 patients (23%), and 4.4% suffered complete vision loss. A higher proportion of patients with visual manifestations reported jaw claudication than did patients without visual changes (55% vs 38%, p = 0.04). Over a period of 55 years, we observed a significant decline in the incidence of visual symptoms due to GCA. There was a lower incidence of ischemic optic neuropathy in the 1980-2004 cohort vs 1950-1979 (6% vs 15%, p = 0.03). Patients diagnosed in later decades were more likely to recover from visual symptoms (HR 1.34, 95% CI 1.06-1.71). Chances of recovery were poor in patients with anterior ischemic optic neuropathy or complete vision loss. Conclusion. Incidence of visual symptoms has declined over the past 5 decades, and chances of recovery from visual symptoms have improved. However, complete loss of vision is essentially irreversible. Jaw claudication is associated with higher likelihood of development of visual symptoms.

KW - Blindness

KW - Giant cell arteritis

KW - Steroids

KW - Vasculitis

KW - Vision loss

KW - Visual manifestations

UR - http://www.scopus.com/inward/record.url?scp=84923125709&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923125709&partnerID=8YFLogxK

M3 - Article

C2 - 25512481

AN - SCOPUS:84923125709

VL - 42

SP - 309

EP - 315

JO - Journal of Rheumatology

JF - Journal of Rheumatology

SN - 0315-162X

IS - 2

ER -